Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Site search
Search
Toggle navigation
Contact Us
Subscribe
Promote Your Event
e-Edition
Privacy Policy
Terms of Service
Local Weather
Home Delivery
Submission Forms
News
Local News
The Leader
Heartland News
Sports
Entertainment
Local Events
Multimedia
Photo Galleries
Videos
Obituaries
Classifieds
Real Estate
Property for Rent
Cars & Vehicles
Jobs
Items for Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place an ad
Legals
Best of 2022
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Mind Medicine Mindmed Inc
(NQ:
MNMD
)
2.910
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 27, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
284,414
Open
2.950
Bid (Size)
2.840 (8)
Ask (Size)
2.950 (6)
Prev. Close
2.910
Today's Range
2.870 - 2.950
52wk Range
2.120 - 19.95
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Psychedelic Stock Gainers And Losers From March 27, 2023
Today 17:30 EDT
Via
Benzinga
GH Research, Cybin Among Top Psychedelic Movers Of Today
March 24, 2023
Via
Benzinga
Performance
YTD
+16.87%
+16.87%
1 Month
-20.71%
-20.71%
3 Month
+28.19%
+28.19%
6 Month
-49.39%
-49.39%
1 Year
-83.28%
-83.28%
More News
Read More
GH Research, Compass Pathways Among Top Psychedelic Movers Of Today
March 23, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 22, 2023
March 22, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 21, 2023
March 21, 2023
Via
Benzinga
EXCLUSIVE: NYC Ketamine Center Co-Founder On Prices, Insurance, Competition & Expansion
March 21, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 20, 2023
March 20, 2023
Via
Benzinga
Cannabis Category Performance Comparisons: An Update
March 19, 2023
Via
Talk Markets
Psychedelic Stock Gainers And Losers From March 17, 2023
March 17, 2023
Via
Benzinga
Seelos Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today
March 16, 2023
Via
Benzinga
Seelos Therapeutics, Cybin Among Top Psychedelic Movers Of Today
March 15, 2023
Via
Benzinga
Seelos Therapeutics, ATAI Life Sciences Among Top Psychedelic Movers Of Today
March 14, 2023
Via
Benzinga
ATAI Life Sciences, Compass Pathways Among Top Psychedelic Movers Of Today
March 13, 2023
Via
Benzinga
Psyched: Next-Gen Compounds For Depression, Congress, Rescheduling, Benzinga Psychedelics Conference & More
March 13, 2023
Via
Benzinga
Major Psychedelics VC & EFT Directors Will Share Valuable Insights At Upcoming Benzinga Event
March 13, 2023
Via
Benzinga
Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today
March 10, 2023
Via
Benzinga
MindMed Reports Full-Year 2022 Financial Results, Highlighting Anxiety & Autism Studies
March 10, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 9, 2023
March 09, 2023
Via
Benzinga
MindMed Reports Full Year 2022 Financial Results and Business Highlights
March 09, 2023
From
MindMed
Via
Business Wire
Numinus Wellness, Seelos Therapeutics Among Top Psychedelic Movers Of Today
March 08, 2023
Via
Benzinga
Cybin, GH Research Among Top Psychedelic Movers Of Today
March 07, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 6, 2023
March 06, 2023
Via
Benzinga
Here Are The Year's Highest Priced Psychedelics Stocks In US Markets
March 06, 2023
Via
Benzinga
The 5 Cannabis Category Performances Have Ranged From +14.5% To -2.7% YTD
March 04, 2023
Via
Talk Markets
Cybin, GH Research Among Top Psychedelic Movers Of Today
March 03, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
